Trending...
- Crimson Cup Congratulates 15 Independent Coffee Shops in 8 States Marking September Anniversaries - 136
- Where the Miami Dolphins Stand After Week 1 - 106
- NoviSign Sponsoring VARTECH 2025 - the B2B IT channel's #1 event - 102
CLEVELAND, Oct. 21, 2024 ~ As the rates of colorectal cancer continue to rise among younger Americans, Reese Pharmaceutical has announced the launch of the second phase of their "Know Your CRC History" campaign. The campaign, also known as #MyCRCHistory, aims to empower families to have open discussions about their colorectal cancer health history during holiday gatherings.
The main focus of this initiative is to educate the public about the increasing accessibility of at-home tests, specifically ColoTest. This at-home fecal immunochemical test (FIT) is now available for purchase in over 7,000 CVS Pharmacy stores nationwide and online at CVS.com. In addition to Walmart and Amazon, this non-invasive test can be used annually by individuals of any age to quickly detect hidden blood in the stool, which may be an indication of colorectal cancer.
According to Jeffrey Reese, President of Reese Pharmaceutical, "The holidays provide a unique opportunity to discuss family health history. This knowledge empowers individuals to get screened earlier and more frequently, helping to minimize their risk." He also emphasizes that with the increased accessibility of ColoTest, taking the first step towards early detection has never been easier and could ultimately save lives.
More on Ohio Pen
The American Cancer Society reports that approximately 20,000 people under the age of 50 are diagnosed with colorectal cancer each year. It is now the leading cause of cancer deaths among men in this age group and the second leading cause for women under 50. Early screening is crucial for those with a family history as they may need to start screenings before the recommended age of 45.
A recent study by Kaiser Permanente found that FIT test screening can reduce the overall risk of colon cancer death by 33%. Despite these proven benefits, FIT testing is still considered underutilized. The #MyCRCHistory campaign aims to bridge this gap in knowledge. It was launched after a survey conducted by Reese Pharmaceutical revealed that 80% of adults are unaware of their first-degree relatives' history with colorectal cancer.
To help families better understand their personal risk, the Colorectal Cancer Alliance offers a quick and easy online quiz. This quiz takes users through their family history, risk factors, and symptoms to determine their screening needs. The quiz can be found at quiz.getscreened.org.
For more information on ColoTest and how you can take proactive steps in your colorectal health, visit Reese Pharmaceutical's website. With the holiday season approaching, it is important for families to have open discussions about their health history and take advantage of the increasing accessibility of at-home tests like ColoTest. Early detection is key in fighting against colorectal cancer and this campaign aims to empower individuals to take control of their health.
The main focus of this initiative is to educate the public about the increasing accessibility of at-home tests, specifically ColoTest. This at-home fecal immunochemical test (FIT) is now available for purchase in over 7,000 CVS Pharmacy stores nationwide and online at CVS.com. In addition to Walmart and Amazon, this non-invasive test can be used annually by individuals of any age to quickly detect hidden blood in the stool, which may be an indication of colorectal cancer.
According to Jeffrey Reese, President of Reese Pharmaceutical, "The holidays provide a unique opportunity to discuss family health history. This knowledge empowers individuals to get screened earlier and more frequently, helping to minimize their risk." He also emphasizes that with the increased accessibility of ColoTest, taking the first step towards early detection has never been easier and could ultimately save lives.
More on Ohio Pen
- Work 365 Launches PV 3.0: The Keystone Power App for Microsoft CSPs
- Local consultant shows small businesses how to turn red tape into real money
- Retirement Expert Mark E. Caner Joins Tom Hegna on the Podcast "Financial Freedom with Tom Hegna"
- Tour Napa Like a Local: Vines of Napa Valley Wine Passport AKA Vine Pass Unlocks Hidden Gems
- Dental Surgical Center Accepts Sedation Patients with Medicaid for MD, WV, PA and DC
The American Cancer Society reports that approximately 20,000 people under the age of 50 are diagnosed with colorectal cancer each year. It is now the leading cause of cancer deaths among men in this age group and the second leading cause for women under 50. Early screening is crucial for those with a family history as they may need to start screenings before the recommended age of 45.
A recent study by Kaiser Permanente found that FIT test screening can reduce the overall risk of colon cancer death by 33%. Despite these proven benefits, FIT testing is still considered underutilized. The #MyCRCHistory campaign aims to bridge this gap in knowledge. It was launched after a survey conducted by Reese Pharmaceutical revealed that 80% of adults are unaware of their first-degree relatives' history with colorectal cancer.
To help families better understand their personal risk, the Colorectal Cancer Alliance offers a quick and easy online quiz. This quiz takes users through their family history, risk factors, and symptoms to determine their screening needs. The quiz can be found at quiz.getscreened.org.
For more information on ColoTest and how you can take proactive steps in your colorectal health, visit Reese Pharmaceutical's website. With the holiday season approaching, it is important for families to have open discussions about their health history and take advantage of the increasing accessibility of at-home tests like ColoTest. Early detection is key in fighting against colorectal cancer and this campaign aims to empower individuals to take control of their health.
Filed Under: Business
0 Comments
Latest on Ohio Pen
- Nebuvex Acknowledges Platform "Too Secure" for Anonymous Traders; Institutional Investors Disagree
- From Tokyo to Berlin: FreeTo.Chat Unites Cultures with the World's First Confession VRX — EmojiStream™
- AZETHIO Launches Multi-Million Dollar User Protection Initiative Following Unprecedented Platform Growth
- Matecrypt Observes South American Cryptocurrency Adoption Surge Amid Economic Shifts
- Assent Uncovers Over 695 Unique PFAS Across Global Supply Chains as Regulations Increase
- Cryptocurrency Quarterly Trading Volume Surpasses $15 Trillion Record High as BrazilNex Acknowledges Industry 'Growing Pains' Amid Market Speculation
- AHRFD Initiates Legal Proceedings Against Anwalt.de for Publishing Defamatory and False Content
- New Analysis Reveals the Complex Forces Driving the 'Great Human Reshuffle'
- Elevate Unveils GroundComm X30 at 2025 International GSE Expo in Las Vegas
- NEW power supply release from Kepco Dynatronix - HSP Advanced
- St. Augustine Honors Hispanic Heritage Month
- Vesica Health Receives AUA Guideline Inclusion
- Steward's Plumbing Sponsors the 2025 Samson Challenge, Bringing Community, Fitness, and Fun Together in Albuquerque
- 10xLaw.com Extends Employment Opportunity to Kim Kardashian
- DecisionPoint Technologies Accelerates Growth with Acquisition of Acuity Technologies
- CCHR: Involuntary Commitment Is Eugenics Repackaged as "Mental Health Care"
- Abundant Frequencies Launches 24/7 Live Stream of 639Hz, 741Hz & 888Hz Healing Sounds
- Q2 2025 Industry Impact Report Underscores Semiconductor Expansion, Talent Development and Sustainability Milestones
- 84 Ethiopian Churches Change Signboards to Shincheonji Church of Jesus
- BTXSGG Outlines Four-Pillar Framework to Enhance Digital Asset Security and Compliance